Navigation Links
FDA approves ipilimumab, an immunotherapy, to treat metastatic melanoma
Date:3/25/2011

New York, NY, Mar. 25, 2011 The U.S. Food and Drug Administration (FDA) announced today its approval of a new treatment for advanced melanoma, the deadliest and most difficult-to-treat form of skin cancer. The drug, a monoclonal antibody called ipilimumab, is the first treatment of any kind ever shown in a large, randomized phase III clinical study (study MDX010-20) to improve overall survival in patients with metastatic melanoma who no longer respond to standard therapy. It is also the first in an emerging class of therapies called "checkpoint blockade," which enhance the immune system's ability to attack cancer by interfering with immunological checkpoints that slow or stop immune cell activation and proliferation in the presence of tumors or chronic viral infection.

"The approval of ipilimumab to treat advanced metastatic melanoma is a game changer not only for the thousands of people fighting this disease, but also for the entire field of oncology," says Jill O'Donnell-Tormey, Ph.D., executive director of the Cancer Research Institute (CRI), a nonprofit organization that since 1953 has worked to advance the science of tumor immunology. "It represents a major leap forward in our understanding of the role the immune system can play in controlling canceran understanding made possible through decades of intensive laboratory and clinical researchand demonstrates how we can now apply this knowledge to develop new and powerful immune-based therapies that extend cancer patients' lives."

New data released earlier this week from another pivotal phase III clinical trial (study CA184-024) show the antibody also extends survival in patients with metastatic melanoma who have not received prior therapy. The study compared the effects of combining ipilimumab with chemotherapy (dacarbazine) versus chemotherapy alone. Although dacarbazine has been part of the standard of care for metastatic melanoma for more than 30 years, it has never been shown to incre
'/>"/>

Contact: Brian Brewer
bbrewer@cancerresearch.org
212-688-7515 x242
Cancer Research Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Kaiser Permanente Approves $170 Million in Community Benefit Grants in 2009
2. The American Association of Anatomists approves guidelines for body donation programs
3. Golden Meditech Shareholders Approves of Name Change
4. New Jersey Approves Initiative to Expand the Number of Wound Care Certified Professionals
5. Congress Approves Bill Curbing Internet Tobacco Sales in Victory for Kids and Taxpayers
6. House of Representatives Approves Health-Care Reform Bill
7. New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
8. FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial
9. FDA approves first human neural stem cell clinical trial to treat brain tumors
10. Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
11. FDA approves Merz Pharmaceuticals Xeomin (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... DC (PRWEB) September 15, 2014 ... payment initiatives that bring providers on board as ... member satisfaction. When bundled payment programs are designed ... financial incentives, incentivize hospitals to work collaboratively with ... procedure-specific tally. On Sept. 24, the Atlantic Information ...
(Date:9/15/2014)... More than 30 million additional Americans ... Care Act. This fact begs the question “are there ... reform and an aging population create a demand for ... are trying to stay on top of the anticipated ... 204 days to fill, according to the Association of ...
(Date:9/15/2014)... FL (PRWEB) September 15, 2014 (PRWEB) September 15, 2014 ... what’s not; what the startup business requirements are in ... the new business. , Speakers include industry professionals, such ... Health Center in Oakland,CA and cannabis business consultant ... , who are already successfully running legal marijuana businesses ...
(Date:9/14/2014)... Petersburg, FL (PRWEB) September 15, 2014 Skin ... external factors like sun damage and not moisturizing properly. However, ... if skin has been cared for. , Two main reasons ... 2) Loss of hyaluronic acid in the skin , During ... and both of these are responsible for important moisture retention ...
(Date:9/14/2014)... (PRWEB) September 14, 2014 Government ... growth of the patient handling equipment market , ... lucrative growth potential for the next five years. ... the rise in geriatric population and increasing lifestyle ... leading to increased disabilities. Further the market is ...
Breaking Medicine News(10 mins):Health News:Sept. 24 Webinar to Profile Geisinger Health System, BCBS of North Carolina’s Successful Bundled-Payment Programs 2Health News:Affordable Care Act Poses Challenge for Hospital Recruiters, with Nationwide Physician Shortage Looming in the Near Future 2Health News:How to Start And Run a Successful Legal Marijuana Business 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:10.7% CAGR For Patient Handling Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4
... , ... (Vocus) December 8, 2008 -- Losing a child to the ... , it is a tragedy they have experienced firsthand. The nonprofit organization ... the flu or have had a child experience severe medical complications from ...
... 8 - 14; Urges Immunization into December, January and Beyond ... Dec. 8 Mothers -- often the family,s primary healthcare ... families vaccinated against influenza throughout the winter months and even ... American Lung Association as part of its Faces of ...
... suggests it,s a promising candidate as marker for metastasis ... that may contribute to the spread of breast cancer ... (called Menainv) is present in invasive cells within a ... biomarker for metastatic breast cancer, the scientists said. , ...
... Technologies(R), a leading,provider of radio frequency identification systems and ... Designed to allow,hospitals easier access to the Safe Place ... financing, this option is especially helpful,in today,s tight economy. ... to offer a new way for hospitals to implement ...
... Conn., Dec. 8 SearchMedica.com,( http://www.searchmedica.com/ ), the ... new Radiology search channel. The search,channel connects radiologists ... relevant online medical imaging resources. , ... medical professional at some point,no matter what their ...
... to keep,families healthy and make it easier to get a ... largest retail health,care clinic in the U.S., announced that they ... this Fall,s flu shot season. , ... (NYSE: CVS ), launched,an integrated campaign on Oct. ...
Cached Medicine News:Health News:For Kids, the Flu Can Be Severe, Even Deadly 2Health News:For Kids, the Flu Can Be Severe, Even Deadly 3Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 2Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 3Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 4Health News:Survey Shows Mothers See Value in Influenza Vaccination for Their Families Through the Winter and Spring 5Health News:Scientists ID Protein Aiding Breast Cancer Spread 2Health News:RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions 2Health News:RF Technologies(R) Introduces Safe Place(R) Usage Program Financing for Its Infant Security, Pediatric Security and ED Safety Solutions 3Health News:SearchMedica Launches Radiology Search Channel for Medical Professionals 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 2Health News:CVS/pharmacy and MinuteClinic Reach Goal of Delivering One Million Flu Vaccinations 3
(Date:9/14/2014)... , September 14, 2014 ... EMITF ) announced today further to the ... 2014 (the "Company,s Previous Reports"), that it was informed ... of US$ 12.5 million by  Shanghai GEOC Hengtong Investment ... Group").In the framework of the present investment round in ...
(Date:9/12/2014)... DUBLIN, Ireland , September ... ,Research and Markets ( ... addition of the  "Global Pipeline ... Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, ... - Trends and Forecast to ...
(Date:9/12/2014)... September 12, 2014 The ... [Beverages (Alcoholic, CSD, Sports & Energy Drinks, Others), ... Meat & Seafood)], by Material (Aluminum & Steel) ... defines and segments the Food & Beverage Metal ... application in terms of volumes and values. The ...
Breaking Medicine Technology:Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 2Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 3Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020 2Global Pipeline Analysis of Hospital Acquired Pneumonia Drugs (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Trends and Forecast to 2020 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4
... International, Inc.,(Nasdaq: DATA ), a technology and services ... industry, today reported its,operating results for the first quarter ... 31, 2008, revenue decreased,approximately 41% to $2,088,000 and the ... share on both a basic and diluted basis. These,results ...
... the treatment of ... schizophrenia and bipolar I disorder, WASHINGTON, May 8 ... of asenapine clinical trials,from the Olympia program was presented at ... D.C., May 3-8. Data from,the studies, involving patients with bipolar ...
Cached Medicine Technology:DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: